Literature DB >> 30700273

Correction to: Concordance analysis of microarray studies identifies representative gene expression changes in Parkinson's disease: a comparison of 33 human and animal studies.

Erin Oerton1, Andreas Bender2.   

Abstract

Following publication of the original article [1], the authors reported the following errors on their article.

Entities:  

Year:  2019        PMID: 30700273      PMCID: PMC6354380          DOI: 10.1186/s12883-019-1240-7

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


Correction to: BMC Neurol (2017) 17:58. https://doi.org/10.1186/s12883-017-0838-x Following publication of the original article [1], the authors reported the following errors on their article. 1) In Table 1, the ‘Average concordance of expression signatures’ of the ‘Basal ganglia’ should be 0.11’ instead of 0.10. 2) The rightmost bar in Fig. 2 should be 0.21 instead of 0.29. Below is the correct version of the figure.
Fig. 2

Average concordance within subgroups of human studies of PD. Concordance increases in studies of human patients (i.e., excluding human cell line studies), and within tissue subgroups. Concordance of pathways compares regulation at the level of biological processes rather than individual genes, and accordingly concordance at the pathway level is generally higher than at the level of differential gene expression

Average concordance within subgroups of human studies of PD. Concordance increases in studies of human patients (i.e., excluding human cell line studies), and within tissue subgroups. Concordance of pathways compares regulation at the level of biological processes rather than individual genes, and accordingly concordance at the pathway level is generally higher than at the level of differential gene expression
  1 in total

1.  Concordance analysis of microarray studies identifies representative gene expression changes in Parkinson's disease: a comparison of 33 human and animal studies.

Authors:  Erin Oerton; Andreas Bender
Journal:  BMC Neurol       Date:  2017-03-23       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.